Executive Director, Worldwide Medical Affairs Disease Area Head, Thoracic & H&N cancers

About the position

We are seeking a dynamic and visionary Worldwide Medical Affairs Disease Area Head (WW-DAH) to oversee our Oncology Worldwide thoracic and head & neck cancers programs. This pivotal role involves shaping and executing the global medical strategy for these disease areas, ensuring scientific excellence, and driving the development of life-changing therapies for patients worldwide. The WW-DAH will collaborate closely with cross-functional teams, including Research & Development, Commercial, and Market Access, to maximize the value of our oncology portfolio and report to the SVP, Head of Worldwide Medical Affairs Oncology.

Responsibilities

• Develop and execute the global medical strategy for thoracic and head & neck oncology, aligning with organizational goals and patient needs.
• Anticipate and respond to dynamic market landscapes, including scientific, regulatory, and competitive challenges, ensuring a leadership position in the global oncology market.
• Collaborate with R&D, Commercial, and Market Access teams to shape pipeline and portfolio strategies that deliver life-changing therapies to patients.
• Identify unmet needs, market trends, and opportunities for new product development or acquisitions in thoracic and head & neck oncology.
• Oversee differentiation strategies and signal-seeking initiatives to expand the pipeline and identify transformative therapeutic opportunities.
• Shape early development strategy and contribute to trial designs and recruitment.
• Ensure appropriate access for patients across US and international markets.
• Oversee the Medical Product Leads (MPL) and AIMs (Asset Integrated Medical Teams) to ensure strategy is co-created with the markets and that asset strategies reflect the needs of our countries while driving top market performance and support.
• Serve as the key medical representative on the brand team and Global Product Teams in development, providing strategic leadership and scientific expertise.
• Collaborate with cross-functional teams to ensure evidence generation efforts support regulatory submissions, reimbursement decisions, and market access strategy.
• Responsible for the Disease area Evidence generation strategies; accountable for the integrated evidence plans and prioritize studies to address key stakeholders' needs, including patients, healthcare providers, and payors.
• Oversee the design and implementation of interventional trials and real-world evidence (RWE) studies, including early signal-seeking studies, investigator-sponsored research (ISR), medical affairs-led studies, post-market studies, registries, and observational research.
• Lead a high-performing, inclusive, and diverse team of medical and scientific professionals, fostering a culture of accountability, collaboration, and empowerment to achieve exceptional results.
• Champion organizational efficiency and agility by implementing streamlined processes that enable seamless global execution of strategic programs, initiatives, and high-impact launches.
• Leverage advanced digital capabilities and data-driven tools to optimize decision-making, enhance stakeholder engagement, and provide actionable insights that shape medical and business strategies.
• Establish and maintain robust systems to ensure a relentless focus on measurable outcomes across all medical activities, tracking and evaluating performance metrics to drive sustained impact, operational excellence, and continuous improvement.
• Serve as the global medical face of the organization in thoracic and head & neck oncology, representing the company with key external stakeholders, including regulatory agencies, academic and community institutions, medical organizations, population decision-makers, and patient advocacy groups.
• Lead efforts to strengthen the company's reputation as the partner of choice in the oncology space by advancing our commitment to patient-centric care and science-driven solutions.
• Establish strategic partnerships to accelerate access, innovation, and scientific collaboration globally.

Requirements

• Medical Degree (MD or equivalent) with clinical experience in oncology preferred.
• 7+ years of leadership experience in the biopharmaceutical industry or academia with a strong track record in oncology and global medical affairs.
• Demonstrated expertise in building and executing global medical and portfolio strategies for marketed and pipeline assets in the relevant disease areas.
• Proven ability to lead and inspire large, diverse, and geographically distributed teams.
• Strong knowledge of global regulatory landscapes, clinical development, access and medical launch excellence.
• Exceptional stakeholder management and communication skills, with the ability to influence and build credibility with senior leadership, external partners, and the global scientific community.

Nice-to-haves

• Strategic thinking and business acumen.
• Excellent communication and interpersonal skills.
• Strong analytical and problem-solving abilities.
• Ability to work collaboratively across functions and geographies.
• Commitment to patient-centric care and scientific excellence.

Benefits

• Competitive benefits, services and programs that provide resources to pursue goals at work and in personal lives.